Antibody to peroxisome proliferator-activated receptor alpha, a nuclear receptor involved in lipid metabolism and inflammation – implicated in various cancers. No cross reactivity on PPAR? and PPAR?.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162423 |
|---|---|
| Research Fields: | Cancer Metabolism |
| Application: | ELISA, WB, ICC, ChIP |
| Target: | PPARa |
| Reactivity: | Human, mouse |
| Clone: | PPAR-2B2 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Antibody to peroxisome proliferator-activated receptor alpha, a nuclear receptor involved in lipid metabolism and inflammation – implicated in various cancers. No cross reactivity on PPAR? and PPAR?. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a, K |
| Immunogen: | Synthetic peptide (DLESPLSEEFLQEMGNI), corresponding to aa 18-34 of mouse PPAR? |
| Target background: | Peroxisome proliferator-activated receptor alpha is a nuclear receptor involved in lipid metabolism and inflammation, and it has been implicated in various cancers. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151017 | Anti-MBP [R29.6] |
Key Info
Anti-MBP [R29.6]
|
View Tool | |||||||||||||||||||
| 151019 | Anti-Mos [S3.1] |
Key Info
Anti-Mos [S3.1]
|
View Tool | |||||||||||||||||||
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.